RFRania Farghaly

Rania Farghaly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rania Farghaly has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immune Modulation of Inflammasome Stimulates NLRP3 and IL-1β Expression in Preeclampsia: Insights into the Role of Anti-Inflammatory Agents in Prevention of Low Birth Weight

    by Ghada M. Ezzat, Ragaa H.M. Salama, Ahmed Abbas, Michel E. Fakhry, Mohammed F. Ramadan, Mustafa M. Kamel, Asmaa S. Shaltout, Oa Sayed, Rania Farghaly

    Background: Preeclampsia remains a leading cause of maternal and neonatal morbidity and mortality. It is characterized by altered local and systemic immune regulation and a rise in proinflammatory cytokines. The inflammasome is a cytosolic protein complex that mediates innate immune responses through promoting the secretion of interleukin-1beta (IL-1β). This study aimed to investigate the nucleotide oligomerization domain (NOD)-like receptor family, pyrin domain-containing protein 3, inflammasome activation in preeclampsia (PE), its relation to IL-1β and their association with PE outcomes. Methods: Placenta and blood were collected from 25 control pregnant women and 50 preeclamptic women. Pyrin domain-containing protein 3 (NLRP3) and IL-1β gene expression were quantified by real-time polymerase chain reaction (PCR). Results: Placental and blood relative gene expression levels of NLRP3 and IL-1β were significantly higher in mild and severe PE than in controls. A significantly higher blood expression of NLRP3 was noticed in the low birth weight subgroup compared to the normal birth weight subgroup (p = 0.03) in the severe PE group. Both biomarkers levels in placenta and blood showed significant negative correlations with the weight of newborn. The strong positive correlation (p < 0.0001, r = 0.9) between NLRP3 and IL-1β suggested that IL-1β response mostly depend on NLRP3 inflammasome. Conclusions: These results suggest the presence of excessive activation of NLRP3 and subsequently increased production of active IL-1β that may predispose placental inflammation in severe PE and subsequently, low neonatal birth weight and shortened gestational age.

  • The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria

    by Tahia Saleem, Marwa Dahpy, Ghada Ezzat, Ghada Abdelrahman, Essam Abdel-Aziz, Rania Farghaly

    Altered plasma levels of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) may predict the development of insulin resistance and other type 2 diabetes mellitus (T2DM) associated comorbidities. To elucidate the role of plasma free amino acids (PFAAs) profile as a biomarker for early detection of diabetic kidney disease, quantitative measurement of PFAAs profile was determined for 90 T2DM subjects, 30 were free of nephropathy, 30 with microalbuminuria, 30 with macroalbuminuria, and in addition to 30 healthy controls. The plasma levels of valine, leucine, isoleucine, phenylalanine, citrulline, and total BCAAs were significantly increased in diabetic normoalbuminuria group when compared to controls. However, the total BCAAs level was significantly decreased in diabetic patients with micro and macroalbuminuria. Other amino acid plasma levels as tyrosine, arginine, ornithine, glycine, and the total AAAs level were significantly decreased in all diabetic subgroups compared to controls. Significant positive correlations between total BCAAs, valine, leucine, isoleucine, serum insulin, glucose, and HOMA-IR values in the diabetic normoalbuminuria group were found. The use of altered PFAAs profile as a prognostic factor in T2DM patients at risk for microalbuminuria or macroalbuminuria might reduce or prevent the incidence of end-stage diabetic renal disease.